Table 1.
Screen | Genotype | Exp mice with lung tumors % (N) | Median survival of exp mice (days) | Ctrl mice with lung tumors % (N) | Median survival of ctrl mice (days) |
---|---|---|---|---|---|
wild-type | Rosa26-LsL-SB11 x T2/Onc x Spc-Cre | 17% (53) | NA* | 12 % (93) | NA* |
p19 | Rosa26-LsL-SB11 x T2/Onc x Spc-Cre x p19ARF−/− | 6% (99) | 303 | 8% (100) | 326 |
p53 | Rosa26-LsL-SB11 x T2/Onc x Spc-Cre x p53+/floxedR270H | 22% (116) | 419 | 15 % (87) | 443 |
Pten | Rosa26-LsL-SB11 x T2/Onc x Spc-Cre x Ptenfloxed/floxed | 29% (62) | 320 | 6 % (94) | 415 |
Median survival of wild-type mice was not determined because the majority lived longer than the endpoint of 1.5 years